CHARLES L. WISSEMAN JR., M.D.; WILLIAM H. WOOD JR., M.D.; ANTONIO R. NORIEGA, M.D.; MARTHA E. JORDAN, PH.D.; DOLORES J. RILL, B.A.
Insecticides, rodenticides, immunoprophylactic measures, and chemotherapeutic agents have combined to minimize the present-day importance of typhus fevers as a cause of death or incapacitation. It is only natural, perhaps, that a state of apathy now exists among medical scientists in this country with regard to the need for further study of diseases such as these that appear to be waning. Yet, epidemic typhus has repeatedly influenced human destiny in a most dramatic fashion (1) and its lesser relative, murine typhus, has had essentially world-wide distribution. Historical records of human behavior and the present world political climate give little reassurance that
CHARLES L. WISSEMAN, WILLIAM H. WOOD, ANTONIO R. NORIEGA, MARTHA E. JORDAN, DOLORES J. RILL. Antibodies and Clinical Relapse of Murine Typhus Fever Following Early Chemotherapy. Ann Intern Med. 1962;57:743–754. doi: 10.7326/0003-4819-57-5-743
Download citation file:
Published: Ann Intern Med. 1962;57(5):743-754.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use